iRadimed(IRMD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

IRMD iRadimed

Closed 03-18 16:00:00 EDT

99.67

-3.13

-3.04%

盘后99.67

+0.000.00%

18:53 EDT

High103.65	Low99.64	Vol80.56K
Open102.37	D1 Closing102.80	Amplitude3.91%
Mkt Cap1.27B	Tradable Cap714.79M	Total Shares12.72M
T/O8.15M	T/O Rate1.12%	Tradable Shares7.17M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"IRMD","market":"US","secType":"STK","nameCN":"iRadimed","latestPrice":99.67,"timestamp":1773864000000,"preClose":102.8,"halted":0,"volume":80557,"hourTrading":{"tag":"盘后","latestPrice":99.67,"preClose":99.67,"latestTime":"18:53 EDT","volume":11333,"amount":1129559.55,"timestamp":1773874430473,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.03044747081712058,"floatShares":7171544,"shares":12721156,"eps":1.75,"marketStatus":"Closed","change":-3.13,"latestTime":"03-18 16:00:00 EDT","open":102.37,"high":103.65,"low":99.635,"amount":8150966.224858,"amplitude":0.039056,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":1.75,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1773907200000},"marketStatusCode":5,"adr":0,"adrRate":0,"listingDate":1405483200000,"exchange":"NASDAQ","adjPreClose":102.8,"dividendRate":0.007124,"postHourTrading":{"tag":"盘后","latestPrice":99.67,"preClose":99.67,"latestTime":"18:53 EDT","volume":11333,"amount":1129559.55,"timestamp":1773874430473,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.061595,"impliedVol":0.3938,"impliedVolPercentile":0.8845},"requestUrl":"/m/hq/s/IRMD","defaultTab":"news","newsList":[{"id":"2620266106","title":"IRadimed CEO Roger E. Susi disposes of USD 0.76 million in common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2620266106","media":"Reuters","labels":["shareholding","insiderTrades"],"top":1,"itemType":null,"share":"https://ttm.financial/m/news/2620266106?lang=en_us&edition=fundamental","pubTime":"2026-03-19 02:11","pubTimestamp":1773857488,"startTime":"0","endTime":"0","summary":"Roger Susi, CEO, president and chairman of IRadimed, reported sales of 3,009 shares on March 16 at a weighted average price of USD 101.18. He also reported sales of 1,991 shares on March 16 at a weighted average price of USD 101.68. Roger Susi reported sales of 2,500 shares on March 17 at a weighted average price of USD 102.43. Following the reported transactions, 2,240,000 shares were reported as indirectly beneficially owned through the Phillip Susi 2008 Dynasty Trust.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IRadimed Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on Mar","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL2mdZf9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"IRadimed CEO Roger E. Susi disposes of USD 0.76 million in common shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IRMD","BK4082"],"gpt_icon":0},{"id":"2620935204","title":"IRADIMED CORPORATION to Participate at the 38th Annual Roth Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2620935204","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620935204?lang=en_us&edition=fundamental","pubTime":"2026-03-17 02:00","pubTimestamp":1773684000,"startTime":"0","endTime":"0","summary":"ORLANDO, Fla., March  16, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) today announced that it will participate in the38th Annual Roth Conference. Iradimed’s CEO, Roger Susi, and CFO, ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/16/3256600/32443/en/IRADIMED-CORPORATION-to-Participate-at-the-38th-Annual-Roth-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","IRMD"],"gpt_icon":0},{"id":"2617263000","title":"IRadimed FY2025 revenue rises 14% to $83.81 million on EPS up 17% to $1.75","url":"https://stock-news.laohu8.com/highlight/detail?id=2617263000","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617263000?lang=en_us&edition=fundamental","pubTime":"2026-03-07 05:07","pubTimestamp":1772831222,"startTime":"0","endTime":"0","summary":"IRadimed Corp. said 2025 revenue rose 14% to 83.81 million, and diluted EPS increased 17% to 1.75. Net income margin was 27% in 2025, up 1 percentage point from 2024. U.S. revenue climbed 16% to 70.56 million, while international revenue increased 5% to 13.26 million. Device revenue rose 16% to 59.98 million, driven by higher unit sales of IV infusion pump systems. Cash provided by operations fell 5% to 24.95 million, and cash and investments ended 2025 at 51.2 million.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IRadimed Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on Marc","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260306:nNDL4X0y4m:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","IRMD"],"gpt_icon":0},{"id":"2611324113","title":"IRADIMED Dividend Hike Follows Record Revenue And New MRI Pump Rollout","url":"https://stock-news.laohu8.com/highlight/detail?id=2611324113","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611324113?lang=en_us&edition=fundamental","pubTime":"2026-02-14 12:47","pubTimestamp":1771044463,"startTime":"0","endTime":"0","summary":"IRADIMED (NasdaqGM:IRMD) has reported its 18th consecutive quarter of record revenue.\nThe company is seeing strong adoption of its existing MRI-compatible devices alongside shipments of its new 3870 infusion pump.\nIRADIMED has raised its regular quarterly dividend, citing confidence supported by future product launches and domestic replacement demand.\n\nAt a share price of $99.81, IRADIMED comes into this news with a 1-year return of 83.6% and a 3-year return of 177.7%. The stock has moved...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-irmd/iradimed/news/iradimed-dividend-hike-follows-record-revenue-and-new-mri-pu","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-irmd/iradimed/news/iradimed-dividend-hike-follows-record-revenue-and-new-mri-pu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4082","IRMD"],"gpt_icon":0},{"id":"2611160002","title":"IRadimed Director Monty K. Allen Reports Sale of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2611160002","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611160002?lang=en_us&edition=fundamental","pubTime":"2026-02-14 04:22","pubTimestamp":1771014132,"startTime":"0","endTime":"0","summary":"Monty K. Allen, a director of IRadimed Corporation, has reported the disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IRadimed Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 13, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260213:nNDL427hCz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"IRadimed Director Monty K. Allen Reports Sale of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IRMD","BK4082"],"gpt_icon":0},{"id":"2610750386","title":"iRadimed price target raised to $120 from $98 at Roth Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2610750386","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610750386?lang=en_us&edition=fundamental","pubTime":"2026-02-11 04:40","pubTimestamp":1770756023,"startTime":"0","endTime":"0","summary":"Roth Capital raised the firm’s price target on iRadimed (IRMD) to $120 from $98 and keeps a Buy rating on the shares following “strong” Q4 results....","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/iradimed-price-target-raised-to-120-from-98-at-roth-capital-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/iradimed-price-target-raised-to-120-from-98-at-roth-capital-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IRMD"],"gpt_icon":0},{"id":"1195580096","title":"Stock Track | iRadimed Soars 8.95% Intraday on Strong Q4 Earnings Beat and Raised Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=1195580096","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195580096?lang=en_us&edition=fundamental","pubTime":"2026-02-10 22:37","pubTimestamp":1770734244,"startTime":"0","endTime":"0","summary":"iRadimed Corporation's stock soared 8.95% during Tuesday's intraday trading session following the release of its fourth quarter and full-year 2025 financial results.The medical device maker reported...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["IRMD"],"gpt_icon":0},{"id":"2610623195","title":"IRadimed Raises Quarterly Dividend by 18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610623195","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610623195?lang=en_us&edition=fundamental","pubTime":"2026-02-10 21:33","pubTimestamp":1770730380,"startTime":"0","endTime":"0","summary":"IRadimed's board has raised the medical-device maker's quarterly dividend by nearly 18%, to 20 cents a share from 17 cents.The new quarterly payout, equal to 80 cents a year, represents an annual yield of about 0.83% based on Monday's closing share price of $95.97, up from 0.71%.The Orlando, Fla., company on Tuesday said the increased dividend is payable March 6 to shareholders of record Feb. 23.In addition to its quarterly dividends, iRadimed paid a 50-cent special dividend last year.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IRMD","BK4082"],"gpt_icon":0},{"id":"2610628292","title":"GUIDANCE: (IRMD) Iradimed Expects 2026 Adjusted EPS Range $2.06 to $2.21, vs. FactSet Est of $2.12","url":"https://stock-news.laohu8.com/highlight/detail?id=2610628292","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610628292?lang=en_us&edition=fundamental","pubTime":"2026-02-10 21:13","pubTimestamp":1770729185,"startTime":"0","endTime":"0","summary":"GUIDANCE: (IRMD) Iradimed Expects 2026 Adjusted EPS Range $2.06 to $2.21, vs. FactSet Est of $2.12","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IRMD"],"gpt_icon":0},{"id":"2610628423","title":"GUIDANCE: (IRMD) IRadimed Expects 2026 Revenue Range $91M to $96M, vs. FactSet Est of $91.1M","url":"https://stock-news.laohu8.com/highlight/detail?id=2610628423","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610628423?lang=en_us&edition=fundamental","pubTime":"2026-02-10 21:11","pubTimestamp":1770729080,"startTime":"0","endTime":"0","summary":"GUIDANCE: (IRMD) IRadimed Expects 2026 Revenue Range $91M to $96M, vs. FactSet Est of $91.1M","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IRMD"],"gpt_icon":0},{"id":"2610628653","title":"IRMD Q4 net income rises 25% to USD 6.4 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2610628653","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610628653?lang=en_us&edition=fundamental","pubTime":"2026-02-10 21:03","pubTimestamp":1770728613,"startTime":"0","endTime":"0","summary":"IRadimed Corporation reported record financial results for the fourth quarter  and full year  2025. Revenue for Q4 2025 reached USD 22.7 million, an increase of 17%. GAAP diluted earnings per share  for Q4 was USD 0.50, up 25%, and non-GAAP diluted EPS was USD 0.54, up 23%. For the full year 2025, IRadimed Corporation reported GAAP diluted EPS of USD 1.75, an increase of 17%, and non-GAAP diluted EPS of USD 1.93, an increase of 16%. The company declared a regular quarterly cash dividend of USD 0.20 per share for Q4 2025, payable on March 6, 2026, representing an increase from USD 0.17 per share. IRadimed Corporation highlighted the successful transition to its new Orlando facility during 2025 and reaffirmed its commitment to innovation and operational efficiency. For 2026, IRadimed Corporation expects full-year revenue in the range of USD 91.0 million to USD 96.0 million, GAAP diluted EPS between USD 1.90 and USD 2.05, and non-GAAP diluted EPS between USD 2.06 and USD 2.21. First quart","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260210:nNDL8x1pB9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IRMD","BK4082"],"gpt_icon":0},{"id":"2610628818","title":"iRadimed Q4 Adj. EPS $0.54 Beats $0.48 Estimate, Sales $22.692M Beat $21.600M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2610628818","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610628818?lang=en_us&edition=fundamental","pubTime":"2026-02-10 21:01","pubTimestamp":1770728515,"startTime":"0","endTime":"0","summary":"iRadimed Q4 Adj. EPS $0.54 Beats $0.48 Estimate, Sales $22.692M Beat $21.600M Estimate","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/02/50506743/iradimed-q4-adj-eps-0-54-beats-0-48-estimate-sales-22-692m-beat-21-600m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IRMD"],"gpt_icon":0},{"id":"2610011640","title":"BRIEF-IRadimed Q4 Revenue USD 22.7 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2610011640","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610011640?lang=en_us&edition=fundamental","pubTime":"2026-02-10 21:00","pubTimestamp":1770728449,"startTime":"0","endTime":"0","summary":"BRIEF-IRadimed Q4 Revenue USD 22.7 Million\n\n\nFeb 10 (Reuters) - IRadimed outlook Q1 revenue USD 21-22 million.\n\noutlook Q1 EPS USD 0.39-0.43\noutlook Q1 adjusted EPS USD 0.44-0.48","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260210:nPLXAD2AF3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IRMD","BK4082"],"gpt_icon":0},{"id":"2610564000","title":"IRadimed Projects 2026 Revenue Up to $96 Million and EPS Up to $2.21","url":"https://stock-news.laohu8.com/highlight/detail?id=2610564000","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610564000?lang=en_us&edition=fundamental","pubTime":"2026-02-10 21:00","pubTimestamp":1770728442,"startTime":"0","endTime":"0","summary":"IRadimed Corporation announced its financial guidance for the full year 2026, projecting revenue in the range of $91.0 million to $96.0 million. The company expects GAAP diluted earnings per share to be between $1.90 and $2.05, and non-GAAP diluted earnings per share between $2.06 and $2.21. For the first quarter of 2026, IRadimed anticipates revenue between $21.0 million and $22.0 million, with GAAP diluted earnings per share ranging from $0.39 to $0.43, and non-GAAP diluted earnings per share between $0.44 and $0.48. The company also announced an increase in its regular quarterly cash dividend to $0.20 per share, up from $0.17 per share, reflecting confidence in its business outlook.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IRa","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260210:nNDL6JrNqg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","LU2210149790.SGD","BK4585","BK4082","BK4588","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","LU0314104364.USD","LU2095319765.USD","IRMD","SG9999014005.SGD","SG9999014013.SGD","SG9999014021.USD","SG9999014039.USD","IE00B64PRP62.GBP","NDAQ","IE00BKPKM429.USD","LU2210150020.SGD"],"gpt_icon":0},{"id":"2610664005","title":"IRadimed Corporation Reports Record Fourth Quarter and Full Year of 2025 Financial Results and Increases Its Regular Quarterly Cash Dividend to $0.20 per Share From $0.17 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2610664005","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610664005?lang=en_us&edition=fundamental","pubTime":"2026-02-10 21:00","pubTimestamp":1770728409,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260210:nTUA8KYSQP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","IRMD"],"gpt_icon":0},{"id":"2610628987","title":"IRadimed Q4 Adjusted EPS USD 0.54","url":"https://stock-news.laohu8.com/highlight/detail?id=2610628987","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610628987?lang=en_us&edition=fundamental","pubTime":"2026-02-10 21:00","pubTimestamp":1770728404,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260210:nPLXAD2AF3:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IRMD","BK4082"],"gpt_icon":0},{"id":"2610164008","title":"IRadimed Outlook Q1 Revenue USD 21-22 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2610164008","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610164008?lang=en_us&edition=fundamental","pubTime":"2026-02-10 21:00","pubTimestamp":1770728404,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260210:nPLXAD2AF3:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","IRMD"],"gpt_icon":0},{"id":"2610064070","title":"IRadimed Outlook Q1 EPS USD 0.39-0.43","url":"https://stock-news.laohu8.com/highlight/detail?id=2610064070","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610064070?lang=en_us&edition=fundamental","pubTime":"2026-02-10 21:00","pubTimestamp":1770728404,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260210:nPLXAD2AF3:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","IRMD"],"gpt_icon":0},{"id":"2610235946","title":"IRADIMED CORPORATION Reports Record Fourth Quarter and Full Year of 2025 Financial Results and Increases its Regular Quarterly Cash Dividend to $0.20 Per Share from $0.17 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2610235946","media":"GlobeNewswire","labels":["shareholding","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610235946?lang=en_us&edition=fundamental","pubTime":"2026-02-10 21:00","pubTimestamp":1770728400,"startTime":"0","endTime":"0","summary":"Reports record revenue of $22.7 million for the fourth quarter of 2025, an increase of $3.3 million, or 17%, compared to the same period in 2024. Reports record GAAP diluted EPS of $0.50 and non-GAAP ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/10/3235234/32443/en/IRADIMED-CORPORATION-Reports-Record-Fourth-Quarter-and-Full-Year-of-2025-Financial-Results-and-Increases-its-Regular-Quarterly-Cash-Dividend-to-0-20-Per-Share-from-0-17-Per-Share.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IRMD","BK4082"],"gpt_icon":0},{"id":"2609078513","title":"The total return for IRADIMED (NASDAQ:IRMD) investors has risen faster than earnings growth over the last five years","url":"https://stock-news.laohu8.com/highlight/detail?id=2609078513","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609078513?lang=en_us&edition=fundamental","pubTime":"2026-02-06 22:59","pubTimestamp":1770389990,"startTime":"0","endTime":"0","summary":"The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But on the bright side, if...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-irmd/iradimed/news/the-total-return-for-iradimed-nasdaqirmd-investors-has-risen-2","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-irmd/iradimed/news/the-total-return-for-iradimed-nasdaqirmd-investors-has-risen-2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":[".IXIC","IRMD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.iradimed.com","stockEarnings":[{"period":"1week","weight":0.039},{"period":"1month","weight":0.03},{"period":"3month","weight":0.0934},{"period":"6month","weight":0.4204},{"period":"1year","weight":0.9731},{"period":"ytd","weight":0.0567}],"compareEarnings":[{"period":"1week","weight":-0.0094},{"period":"1month","weight":-0.0161},{"period":"3month","weight":-0.0009},{"period":"6month","weight":0.0129},{"period":"1year","weight":0.1827},{"period":"ytd","weight":-0.0163}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; MRI compatible patient vital signs monitoring system; and 3600 FMD1 with RALU ferromagnetic detection device. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.","yearOnYearQuotes":[{"month":1,"riseRate":0.583333,"avgChangeRate":0.00574},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.026329},{"month":3,"riseRate":0.666667,"avgChangeRate":0.035868},{"month":4,"riseRate":0.454545,"avgChangeRate":-0.018732},{"month":5,"riseRate":0.727273,"avgChangeRate":0.046771},{"month":6,"riseRate":0.818182,"avgChangeRate":0.064586},{"month":7,"riseRate":0.636364,"avgChangeRate":0.062294},{"month":8,"riseRate":0.583333,"avgChangeRate":0.015264},{"month":9,"riseRate":0.416667,"avgChangeRate":-0.009324},{"month":10,"riseRate":0.583333,"avgChangeRate":0.012732},{"month":11,"riseRate":0.833333,"avgChangeRate":0.103952},{"month":12,"riseRate":0.666667,"avgChangeRate":0.035709}],"exchange":"NASDAQ","name":"iRadimed","nameEN":"iRadimed"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"iRadimed(IRMD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest iRadimed(IRMD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"iRadimed,IRMD,iRadimed股票,iRadimed股票老虎,iRadimed股票老虎国际,iRadimed行情,iRadimed股票行情,iRadimed股价,iRadimed股市,iRadimed股票价格,iRadimed股票交易,iRadimed股票购买,iRadimed股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"iRadimed(IRMD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest iRadimed(IRMD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction